KRO trades 25.6% below Wall Street's consensus target of $7.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes KRO achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Kronos Worldwide, Inc. (KRO) has a Wall Street consensus price target of $7.50, based on estimates from 7 covering analysts. With the stock currently trading at $5.97, this represents a potential upside of +25.6%. The company has a market capitalization of $687M.
Analyst price targets range from a low of $5.00 to a high of $10.00, representing a 67% spread in expectations. The median target of $7.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, KRO trades at a trailing P/E of -6.2x. Analysts expect EPS to grow +94.4% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
TROXTronox Holdings plc | $976M | $6.12 | $8.33 | +36.1% | Buy | — | 17 |
VHIValhi, Inc. | $376M | $13.30 | — | — | Sell | 3.8x | 1 |
HUNHuntsman Corporation | $1.9B | $10.97 | $13.60 | +24.0% | Hold | — | 33 |
CCThe Chemours Company | $2.8B | $18.85 | $25.75 | +36.6% | Hold | 13.6x | 20 |
EMNEastman Chemical Company | $8.0B | $69.62 | $79.44 | +14.1% | Buy | 10.9x | 35 |
RPMRPM International Inc. | $13.9B | $108.28 | $124.67 | +15.1% | Buy | 19.7x | 22 |
SHWThe Sherwin-Williams Company | $84.4B | $342.26 | $374.56 | +9.4% | Buy | 29.2x | 38 |
PPGPPG Industries, Inc. | $26.9B | $120.22 | $129.43 | +7.7% | Buy | 15.3x | 38 |
IFFInternational Flavors & Fragrances Inc. | $20.9B | $81.83 | $88.38 | +8.0% | Buy | 18.5x | 33 |
NEMNewmont Corporation | $105.3B | $95.06 | $144.88 | +52.4% | Buy | 9.4x | 36 |
Quick answers to the most common questions about buying KRO stock.
The consensus Wall Street price target for KRO is $7.5, representing 25.6% upside from the current price of $5.97. With 7 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
KRO has a consensus rating of "Hold" based on 7 Wall Street analysts. The rating breakdown is leaning bearish, with 2 Sell/Strong Sell ratings. The consensus 12-month price target of $7.5 implies 25.6% upside from current levels.
KRO's current price is $5.97 with a consensus target of $7.5 (25.6% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $10 for KRO, while the most conservative target is $5. The consensus of $7.5 represents the median expectation. These targets typically reflect 12-month expectations.
KRO is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 4 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month KRO stock forecast based on 7 Wall Street analysts shows a consensus price target of $7.5, with estimates ranging from $5 (bear case) to $10 (bull case). The median consensus rating is "Hold".
Wall Street analysts are very optimistic on KRO, with a "Hold" consensus rating and $7.5 price target (25.6% upside). 1 of 7 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
KRO analyst price targets range from $5 to $10, a 67% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $7.5 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.